Cancer of the Vagina

  • C. A. Perez
Chapter
Part of the Medical Radiology book series (MEDRAD)

Abstract

Primary malignant tumors of the vagina arise in this organ; there should be documentation that the lesion does not involve the cervix or vulva. It is a rare tumor, representing l%-2% of all gynecologic malignancies (Daw 1971; Herbst et al. 1970; Robboy et al. 1975). Most vaginal neoplasms (more than 80%) are metastatic, involving the vagina by direct extension or by lymphatic or hematogenous routes (Hillborne and Fu 1987).

Keywords

Obstet Gynecol Pelvic Exenteration Smooth Muscle Tumor Verrucous Carcinoma Clear Cell Adenocarcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aartsen EJ, Delemarre JFM, Gerretsen G (1993) Endodermal sinus tumor of the vagina: radiation therapy and progeny. Obstet Gynecol 81:893–895PubMedGoogle Scholar
  2. Antonioli DA, Burke L (1975) Vaginal adenosis: analysis of 325 biopsy specimens from 100 patients. Am J Clin Pathol 64:625–638PubMedGoogle Scholar
  3. Antonioli DA, Rosen S, Burke L, Donahue V (1979) Glandular dysplasia in diethylstilbestrol-associated vaginal adenosis. Am J Clin Pathol 71:715–721PubMedGoogle Scholar
  4. Audet-LaPointe P, Body G, Vauclair R, Drouin P, Ayoub J (1990) Vaginal intraepithelial neoplasia. Gynecol Oncol 36:232–239PubMedGoogle Scholar
  5. Baltzer J, Zander J (1989) Primary squamous cell carcinoma of the neovagina. Gynecol Oncol 35:99–103PubMedGoogle Scholar
  6. Barber HRK, Sommers SC (1974) Vaginal adenosis, dysplasia, and clear cell adenocarcinoma after diethylstilbestrol treatment in pregnancy. Obstet Gynecol 43:645–652PubMedGoogle Scholar
  7. Belinson JL, Stewart JA, Richards AL, McClure M (1985) Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell cancer. Gynecol Oncol 20:387–393PubMedGoogle Scholar
  8. Bell HG, Berman ML (1982) Management of primary vaginal carcinoma. Gynecol Oncol 14:154–163Google Scholar
  9. Benedet JL, Murphy KJ, Fairey RN, Boyes DA (1983) Primary invasive carcinoma of the vagina. Obstet Gynecol 62:715–719PubMedGoogle Scholar
  10. Berchuck A, Rodriguez G, Kamel A, Soper JT, Clarke-Pearson DL, Bast RC Jr (1990) Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina. Obstet Gynecol 76:381–387PubMedGoogle Scholar
  11. Berkowitz RS, Ehrmann RL, Knapp RC (1978) Endometrial stromal sarcoma arising from vaginal endometriosis. Obstet Gynecol 51:34S-37SPubMedGoogle Scholar
  12. Berman ML, Tobon H, Surti U (1981) Primary malignant melanoma of the vagina: clinical, light, and electron microscopic observations. Am J Obstet Gynecol 139:963PubMedGoogle Scholar
  13. Bertoni F, Bertoni G, Bignardi M (1983) Vaginal molds for intracavitary curietherapy: a new method of preparation. Int J Radiat Oncol Biol Phys 9:1579–1582PubMedGoogle Scholar
  14. Boice JD Jr, Engholm G, Kleinerman RA, et al. (1988) Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 116:3–55PubMedGoogle Scholar
  15. Bonner JA, Perez-Tamayo C, Reid GC, Roberts JA, Morley GW (1988) The management of vaginal melanoma. Cancer 62:2066–2072PubMedGoogle Scholar
  16. Bornstein J, Adam E, Adler-Storthz K, Kaufman RH (1988) Development of cervical and vaginal squamous cell neoplasia as a late consequence of in utero exposure to diethylstilbestrol. Obstet Gynecol Surv 43:15–21PubMedGoogle Scholar
  17. Boronow RC, Hickman BT, Reagan MT, Smith RA, Steadham RE (1987) Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer. II. Results, complications, and dosimetric and surgical considerations. Am J Clin Oncol 10:171–181PubMedGoogle Scholar
  18. Brand E, Fu YS, Lagasse LD, Berek JS (1989) Vulvovaginal melanoma: report of seven cases and literature review. Gynecol Oncol 33:54–60PubMedGoogle Scholar
  19. Brinton LA, Nasca PC, Mallin K, et al. (1990) Case-control study of in situ and invasive carcinoma of the vagina. Gynecol Oncol 38:49–54PubMedGoogle Scholar
  20. Brown GR, Fletcher GH, Rutledge FN (1971) Irradiation of “in situ” and invasive squamous cell carcinomas of the vagina. Cancer 28:1278–1283PubMedGoogle Scholar
  21. Burke L, Antonioli D, Friedman EA (1981) Evolution of diethylstilbestrol-associated genital tract lesions. Obstet Gynecol 57:79–84PubMedGoogle Scholar
  22. Buscema J, Rosenshein NB, Taqi F, Woodruff JD (1985) Vaginal hemangiopericytoma: a histopathologic and ultra-structural evaluation. Obstet Gynecol 66:82SGoogle Scholar
  23. Cavanaugh D, Praphat H, Ruffolo EH (1980) Cancer of the vagina. Obstet Gynecol Ann 9:311–325Google Scholar
  24. Chang YCF, Hricak H, Thurnher S, Lacey CG (1988) Vagina: evaluation with MR imaging. II. Neoplasms. Radiology 169:175–179PubMedGoogle Scholar
  25. Chapman GW, Genda J, Williams T (1984) Alveolar soft-part sarcoma of the vagina. Gynecol Oncol 18:125PubMedGoogle Scholar
  26. Chau PM (1963) Radiotherapeutic management of malignant tumors of the vagina. Am J Roentgenol Radium Ther Nucl Med 89:502–523PubMedGoogle Scholar
  27. Chen KTK, Hafez GR, Gilbert EF (1980) Myxoid variant of epithelioid smooth muscle tumor. Am J Clin Pathol 74:350–353PubMedGoogle Scholar
  28. Choo YC, Anderson DG (1982) Neoplasms of the vagina following cervical carcinoma. Gynecol Oncol 14:125–132PubMedGoogle Scholar
  29. Choo YC, Morley GW (1980) Multiple primary neoplasms of the anogenital region. Obstet Gynecol 56:365–369PubMedGoogle Scholar
  30. Chorlton I, Karnei RF, King FM, Norris HJ (1974) Primary malignant reticuloendothelial disease involving the vagina, cervix, and corpus uteri. Obstet Gynecol 44:735–748PubMedGoogle Scholar
  31. Chu AM, Beechinor R (1984) Survival and recurrence patterns in the radiation treatment of carcinoma of the vagina. Gynecol Oncol 19:298PubMedGoogle Scholar
  32. Chung AF, Casey MJ, Flannery JT, Woodruff JM, Lewis JL Jr (1980) Malignant melanoma of the vagina: report of 19 cases. Obstet Gynecol 55:720–727PubMedGoogle Scholar
  33. Copeland LJ, Gershenson DM, Saul PB, Sneige N, Stringer CA, Edwards CL (1985) Sarcoma botryoides of the female genital tract. Obstet Gynecol 66:262–266PubMedGoogle Scholar
  34. Curtis P, Shepherd JH, Lowe DG, Jobling T (1992) The role of partial colpectomy in the management of persistent vaginal neoplasia after primary treatment. Br J Obstet Gynaecol 99:587–589PubMedGoogle Scholar
  35. Dancuart F, Delclos L, Wharton JT, Silva EG (1988) Primary squamous cell carcinoma of the vagina treated by radiotherapy: a failures analysis — the M.D. Anderson Hospital experience 1955–1982. Int J Radiat Oncol Biol Phys 14:745–749PubMedGoogle Scholar
  36. Daniel WW, Koss LG, Brunschwig A (1959) Sarcoma botryoides of the vagina. Cancer 12:74PubMedGoogle Scholar
  37. Davis KP, Stanhope CR, Garton GR, Arkinson EJ, O’Brien PC (1991) Invasive vaginal carcinoma: analysis of early-stage disease. Gynecol Oncol 42:131–136PubMedGoogle Scholar
  38. Davos I, Abell MR (1976) Sarcoma of the vagina. Obstet Gynecol 4:342–350Google Scholar
  39. Daw E (1971) Primary carcinoma of the vagina. J Obstet Gynecol Br Commonw 78:853Google Scholar
  40. Delclos L (1984) Gynecologic cancers: pelvic examination and treatment planning. In: Levitt SH, Tapley N (eds) Technological basis of radiation therapy: practical clinical applications. Lea & Febiger, Philadelphia, pp 193–227Google Scholar
  41. Digel CA, Lastner GMF, Zinreich ES (1989) The use of transmission block in the radiation therapy portal for treatment of the inguinal nodes in late stage pelvic malignancies. Radiol Technol 53:227–232Google Scholar
  42. Ebner F, Kressel HY, Mintz MC, et al. (1988) Tumor recurrence versus fibrosis in the female pelvis: differentiation with MR at 1.5 T. Radiology 166:333–340PubMedGoogle Scholar
  43. Faaborg LL, Smith ML, Newland JR (1979) Uterine cervical and vaginal verrucous squamous cell carcinoma. Gynecol Oncol 8:104–109PubMedGoogle Scholar
  44. Flamant F, Gerbaulet A, Nihoul-Fekete C, Valteau-Couanet D, Chassagne D, Lemerle J (1990) Long-term sequelae of conservative treatment by surgery, brachytherapy, and chemotherapy for vulval and vaginal rhabdomyosarcoma in children. J Clin Oncol 8:1847–1853PubMedGoogle Scholar
  45. Fletcher GH (1980a) Tumors of the vagina and female urethra. In: Fletcher GH (ed) Textbook of radiotherapy, 3rd edn. Lea & Febiger, Philadelphia, pp 821–824Google Scholar
  46. Fletcher GH (1980b) Squamous cell carcinoma of the uterine cervix. In: Fletcher GH (ed) Textbook of radiotherapy, 3rd edn. Lea & Febiger, Philadelphia, pp 720–773Google Scholar
  47. Forsberg JG (1975) Late effects in the vaginal and cervical epithelia after injections of diethylstibestrol into neonatal mice. Am J Obstet Gynecol 121:101PubMedGoogle Scholar
  48. Fowler WC, Brantley JC, Edelman DA (1979) Clear cell adenocarcinoma of the genital tract. South Med J 72:15–16PubMedGoogle Scholar
  49. Fowler WC, Schmidt G, Edelman DA, Kaufman DG, Fenoglio CM (1981) Risks of cervical intraepithelial neoplasia among DES-exposed women. Obstet Gynecol 58:720–724PubMedGoogle Scholar
  50. Frick HC II, Jacox HW, Taylor HC Jr (1968) Primary carcinoma of the vagina. Am J Obstet Gynecol 101:695Google Scholar
  51. Friedman M, Peretz BA, Nissenbaum M, Paldi E (1986) Modern treatment of vaginal embryonal rhabdomyosarcoma. Obstet Gynecol Surv 41:614–618PubMedGoogle Scholar
  52. Friedrich EG, Wilkinson EJ, Sui YS (1980) Carcinoma in situ of the vulva: a continuing challenge. Am J Obstet Gynecol 136:830PubMedGoogle Scholar
  53. Fukushima M, Twiggs LB, Okagaki T (1986) Mixed intestinal adenocarcinoma-argentaffin carcinoma of the vagina. Gynecol Oncol 23:387PubMedGoogle Scholar
  54. Gallup DG, Talledo E, Shah KJ, Hayes C (1987) Invasive squamous cell carcinoma of the vagina: a 14-year study. Obstet Gynecol 69:782–785PubMedGoogle Scholar
  55. Ghavimi F, Exelby PR, D’Angio GJ, et al. (1975) Multidis-ciplinary treatment of embryonal rhabdomyosarcoma in children. Cancer 35:677–686PubMedGoogle Scholar
  56. Ghavimi F, Herr H, Jereb B, Exelby PR (1984) Treatment of genitourinary rhabdomyosarcoma in children. J Urol 132:313–319PubMedGoogle Scholar
  57. Glazer HS, Lee JKT, Levitt RG, et al. (1985) Radiation fibrosis: differentiation from recurrent tumor by MR imaging. Radiology 156:721–726PubMedGoogle Scholar
  58. Granai CO, Walters MD, Safaii H, Jelen I, Madoc-Jones H, Moukhtar M (1984) Malignant transformation of vaginal endometriosis. Obstet Gynecol 64:592–595PubMedGoogle Scholar
  59. Grosfeld JL, Smith JP, Clatworthy W (1972) Pelvic rhabdomyosarcoma in infants and children. J Urol 107:673–675PubMedGoogle Scholar
  60. Harris NL, Scully RE (1984) Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. Cancer 53:2530PubMedGoogle Scholar
  61. Harrison LB, Fogel TD, Peschel RE (1987) Primary vaginal cancer and vaginal melanoma: a review of therapy with external beam radiation and a simple intracavitary brachytherapy system. Endocurietherapy/Hyperthermia Oncol 3:67–72Google Scholar
  62. Hart WR, Townsend DE, Aldrich JO, Henderson BE, Roy M, Benton B (1976) Histopathologic spectrum of vaginal adenosis and related changes in stilbestrol-exposed females. Cancer 37:763PubMedGoogle Scholar
  63. Harwood AR, Cummings BJ (1982) Radiotherapy for mucosal melanomas. Int J Radiat Oncol Biol Phys 8:1121PubMedGoogle Scholar
  64. Hays DM, Shimada H, Raney RB, Tefft M, Newton W, Christ WM, Lawrence W, Ragab A, Maurer HM (1985) Sarcomas of the vagina and uterus: the Intergroup Rhabdomyosarcoma Study. J Pediatr Surg 20:718–724PubMedGoogle Scholar
  65. Helders RD, Malkasian GD, Soule EH (1972) Embryonal rhabdomyosarcoma of the vagina. Am J Obstet Gynecol 107:484–502Google Scholar
  66. Herbst AL (1981) Clear cell adenocarcinoma and the current status of DES-exposed females. Cancer 48:484PubMedGoogle Scholar
  67. Herbst AL (1988) The effects in the human of diethylstilbestrol (DES) use during pregnancy. In: Miller RW, Takamatsu NO, Miya HI, Gan K (eds) Unusual occurrences as clues to cancer etiology. Taylor & Francis, Tokyo, pp 67–75Google Scholar
  68. Herbst AL, Anderson D (1990) Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. Semin Surg Oncol 6:343–346PubMedGoogle Scholar
  69. Herbst AL, Scully RE (1970) Adenocarcinoma of the vagina in adolescence: a report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer 25:745PubMedGoogle Scholar
  70. Herbst AL, Green TH Jr, Ulfelder H (1970) Primary carcinoma of the vagina. Am J Obstet Gynecol 106:210–218PubMedGoogle Scholar
  71. Herbst AL, Ulfelder H, Poskanzer DC (1971) Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284:878–881PubMedGoogle Scholar
  72. Herbst AL, Robboy SJ, Scully RE, Poskanzer DC (1974) Clear-cell adenocarcinoma of the vagina and cervix in girls: Analysis of 170 Registry cases. Am J Obstet Gynecol 119:713–724PubMedGoogle Scholar
  73. Hicks ML, Piver MS (1992) Conservative surgery plus adjuvant therapy for vulvovaginal rhabdomyosarcoma, diethylstilbestrol clear cell adenocarcinoma of the vagina, and unilateral germ cell tumors of the ovary. Obstet Gynecol Clin North Am 19:219–233PubMedGoogle Scholar
  74. Hilborne LH, Fu YS (1987) Intraepithelial, invasive and metastatic neoplasms of the vagina. In: Wilkinson EJ (ed) Pathology of the vulva and vagina. Churchill Livingstone, New York, p 184Google Scholar
  75. Hilgers RD (1975) Pelvic exenteration for vaginal embryonal rhabdomyosarcoma: a review. Obstet Gynecol 45:175–180PubMedGoogle Scholar
  76. Hintz GL, Kagan AR, Chan P, Gilbert HA, Nussbaum H, Rao AR, Wollin M (1980) Radiation tolerance of the vaginal mucosa. Int J Radiat Oncol Biol Phys 6:711–716PubMedGoogle Scholar
  77. Hiura M, Nagai N (1985) Vaginal hemangiopericytoma: a light microscopic and ultrastructural study. Gynecol Oncol 21:376PubMedGoogle Scholar
  78. Hoffman MS, DeCesare SL, Roberts WS, Fiorica JV, Finan MA, Cavanagh D (1992) Upper vaginectomy for in situ and occult, superficially invasive carcinoma of the vagina. Am J Obstet Gynecol 166:30–33PubMedGoogle Scholar
  79. Holton CP, Chapman KE, Lackey RW, Hatch EI, Baum ES, Favara BE (1973) Extended combination therapy of childhood rhabdomyosarcoma. Cancer 32:1310–1316PubMedGoogle Scholar
  80. Hopkins MP, Morley GW (1987) Squamous cell carcinoma of the neovagina. Obstet Gynecol 69:525–527PubMedGoogle Scholar
  81. Hopkins MP, Kumar NB, Lichter AS, Peters WA III, Morley GW (1989) Small cell carcinoma of the vagina with neuroendocrine features: a report of three cases. J Reprod Med 34:486–491PubMedGoogle Scholar
  82. Horwitz RI, Viscoli CM, Merino M, Brennan TA, Flannery JT, Robboy SJ (1988) Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstil-bestrol. J Clin Epidemiol 41:593–597PubMedGoogle Scholar
  83. Hoskins WJ, Perez C, Young RC (1989) Gynecologic tumors. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 3rd edn. Lippincott, Philadelphia, pp 1099–1161Google Scholar
  84. Hricak H, Lacey CG, Sandles LG, Chang YC, Winkler ML, Stern JL (1988) Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology 166:623–631PubMedGoogle Scholar
  85. Iverson K, Robins RE (1980) Mucosal malignant melanomas. Am J Surg 139:660Google Scholar
  86. Kanbour AI, Klionsky B, Murphy AL (1974) Carcinoma of the vagina following cervical cancer. Cancer 34:1838PubMedGoogle Scholar
  87. Kasai K, Yoshida Y, Okumura M (1980) Alveolar soft part sarcoma in the vagina: clinical features and morphology. Gynecol Oncol 9:227PubMedGoogle Scholar
  88. Katib S, Kuten A, Steiner M, Yudelev M, Robinson E (1985) The effectiveness of multidrug treatment by bleomycin, methotrexate, and cisplatin in advanced vaginal carcinoma. Gynecol Oncol 21:101–102PubMedGoogle Scholar
  89. Kaufman RH, Korhonen MO, Strama T, Adam E, Kaplan A (1982) Development of clear cell adenocarcinoma in DES-exposed offspring under observation. Obstet Gynecol 59:68S-72SPubMedGoogle Scholar
  90. Kilman JM, Clatworthy HW Jr, Newton WA Jr, et al. (1973) Reasonable surgery for rhabdomyosarcoma: a study of 67 cases. Ann Surg 178:346–351PubMedGoogle Scholar
  91. Kraus FT, Perez-Mesa C (1966) Verrucous carcinoma: cervical and pathologic study of 105 cases involving oral cavity, larynx and genitalia. Cancer 19:27Google Scholar
  92. Kucera H, Vavra N (1991) Radiation management of primary carcinoma of the vagina: clinical and histopathological variables associated with survival. Gynecol Oncol 40:12–16PubMedGoogle Scholar
  93. Kucera H, Langer M, Smekal G, Weghaupt K (1985) Radio-therapy of primary carcinoma of the vagina: management and results of different therapy schemes. Gynecol Oncol 21:87–93PubMedGoogle Scholar
  94. Kurman RJ, Scully RE (1974) The incidence and histogenesis of vaginal adenosis: an autopsy study. Hum Pathol 5: 265PubMedGoogle Scholar
  95. Lamont A (1984) Wondgenesing en wondhegting (wound healing and suturing). South African J Cont Med Ed 2:95–99Google Scholar
  96. Laufe LE, Bernstein ED (1971) Primary malignant melanoma of the vagina. Obstet Gynecol 37:148–154PubMedGoogle Scholar
  97. Lee JY, Perez CA, Ettinger N, Fineberg BB (1982) The risk of second primaries subsequent to irradiation for cervix cancer. Int J Radiat Oncol Biol Phys 8:207–211PubMedGoogle Scholar
  98. Lee RA, Symmonds RE (1976) Recurrent carcinoma in situ of the vagina in patients previously treated for in situ carcinoma of the cervix. Obstet Gynecol 48:61–64PubMedGoogle Scholar
  99. Leung S, Sexton M (1993) Radical radiation therapy for carcinoma of the vagina: impact of treatment modalities on outcome: Peter MacCallum Cancer Institute experience 1970–1990. Int J Radiat Oncol Biol Phys 25:413–418PubMedGoogle Scholar
  100. Levitan Z, Gordon AN, Kaplan AL, Kaufman RH (1989) Primary malignant melanoma of the vagina: report of four cases and review of the literature. Gynecol Oncol 33:85–90PubMedGoogle Scholar
  101. Lindeque BG (1987) The role of surgery in the management of carcinoma of the vagina. Baillieres Clin Obstet Gynaecol 1:319–329PubMedGoogle Scholar
  102. Lindeque BG, Monaghan JM (to be published) The role of surgery in the management of primary vaginal cancer. J Obstet GynecolGoogle Scholar
  103. Livingstone RC (1950) Primary carcinoma of the vagina. Thomas, Springfield, ILLGoogle Scholar
  104. MacNaught R, Symmonds RP, Hole D, Watson ER (1986) Improved control of primary vaginal tumors by combined external beam and interstitial radiotherapy. Clin Radiol 37:29–32PubMedGoogle Scholar
  105. Magrina JF, Masterson BJ (1981) Vaginal reconstruction in gynecologic oncology: a review of techniques. Obstet Gynecol Surv 36:1–10PubMedGoogle Scholar
  106. Mahesh Kumar APM, Wrenn EL Jr, Fleming ID, Omar Hustu H, Pratt CB (1976) Combined therapy to prevent complete pelvic exenteration for rhabdomyosarcoma of the vagina or uterus. Cancer 37:118–122Google Scholar
  107. Manetta A, Pinto JL, Larson JE, Stevens CW Jr, Pinto JS, Podczaski ES (1988) Primary invasive carcinoma of the vagina. Obstet Gynecol 72:77–81PubMedGoogle Scholar
  108. Manetta A, Gutrecht EL, Berman ML, DiSaia PJ (1990) Primary invasive carcinoma of the vagina. Obstet Gynecol 76:639–642PubMedGoogle Scholar
  109. Marcus RB, Million RR, Daly JW (1978) Carcinoma of the vagina. Cancer 42:2507–2512PubMedGoogle Scholar
  110. Mattingly RF, Stafl A (1976) Cancer risk in diethylstilbestrol-exposed offspring. Am J Obstet Gynecol 126:543PubMedGoogle Scholar
  111. Melnick S, Cole P, Anderson D, Herbst A (1987) Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: an update. N Engl J Med 316:514–516PubMedGoogle Scholar
  112. Morrow CP, DiSaia PJ (1976) Malignant melanoma of the female genitalia: a clinical analysis. Obstet Gynecol Surv 31:233PubMedGoogle Scholar
  113. Muench PJ, Nath R (1992) Dose distributions produced by shielded applicators using241Am for intracavitary irradiation of tumors in the vagina. Med Phys 19:1299–1306PubMedGoogle Scholar
  114. Muss HB, Bundy BN, DiSaia PJ, Homesley HD, Fowler WC Jr, Creasman W, Yordan E (1985) Treatment of recurrent or advanced uterine sarcoma: a randomized trial of doxorubicin versus doxorubicin and cyclophosphamide. Cancer 55:1648–1653PubMedGoogle Scholar
  115. Muss HB, Bundy BN, Christopherson WA (1989) Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. Am J Clin Oncol 12:142–144PubMedGoogle Scholar
  116. Nanavati PJ, Fanning J, Hilgers RD, Hallstrom J, Crawford D (1993) High-dose-rate brachytherapy in primary stage I and II vaginal cancer. Gynecol Oncol 51:67–71PubMedGoogle Scholar
  117. Ng AB, Reagan JW, Hawliczek S, Wentz WB (1975) Cellular detection of vaginal adenosis. Obstet Gynecol 46:323–328PubMedGoogle Scholar
  118. Noller KL, Townsend DE, Kaufman RH, et al. (1983) Maturation of vaginal and cervical epithelium in women exposed in utero to diethylstilbestrol (DESAD Project). Am J Obstet Gynecol 146:279–285PubMedGoogle Scholar
  119. Nori D, Hilaris BS, Stanimir G, Lewis JL Jr (1983) Radiation therapy of primary vaginal carcinoma. Int J Radiat Oncol Biol Phys 9:1471PubMedGoogle Scholar
  120. Norris HJ, Taylor HB (1966) Melanomas of the vagina. Am J Clin Pathol 46:420–426PubMedGoogle Scholar
  121. O’Brien PC, Noller KL, Robboy SJ, Barnes AB, Kaufman RH, Tilley BC, Townsend DE (1979) Vaginal epithelial changes in young women enrolled in the national cooperative diethylstilbestrol adenosis (DESAD) project. Obstet Gynecol 53:300–308PubMedGoogle Scholar
  122. Okagaki T, Ishida T, Hilgers RD (1976) A malignant tumor of the vagina resembling synovial sarcoma: a light and electron microscopic study. Cancer 37:2306PubMedGoogle Scholar
  123. Omura GA, Shingleton HM, Creasman WT, Blessing JA, Boronow RC (1978) Chemotherapy of gynecologic cancer with nitosoureas: a randomized trial of CCNU and methyl-CCNU in cancer of the cervix, corpus, vagina, and vulva. Cancer Treat Rep 62:833–835PubMedGoogle Scholar
  124. Patton TJ, Kavahagh JJ, Delclos L, et al. (1991) Five-year survival in patients given intra-arterial chemotherapy prior to radiotherapy for advanced squamous carcinoma of the cervix and vagina. Gynecol Oncol 42:54–59PubMedGoogle Scholar
  125. Perez CA (1992) Vagina. In: Perez CA, Brady LW (eds) Principles and practice of radiation oncology, 2nd edn. Lippincott, Philadelphia, pp 1258–1272Google Scholar
  126. Perez CA, Camel HM (1982) Long-term follow-up in radiation therapy of carcinoma of the vagina. Cancer 49:1308–1315PubMedGoogle Scholar
  127. Perez CA, Madoc-Jones H (1987) Carcinoma of the vagina. In: Perez CA, Brady LW (eds) Principles and practice of radiation oncology. Lippincott, Philadelphia, pp 1023–1035Google Scholar
  128. Perez CA, Arneson AN, Galakatos A, Samath HK (1973) Malignant tumors of the vagina. Cancer 31:36–44PubMedGoogle Scholar
  129. Perez CA, Arneson AN, Dehner LP, Galakatos A (1974) Radiation therapy in carcinoma of the vagina. Obstet Gynecol 44:862–872PubMedGoogle Scholar
  130. Perez CA, Korba A, Sharma S (1977) Dosimetric considerations in irradiation of carcinoma of the vagina. Int J Radiat Oncol Biol Phys 2:639–649PubMedGoogle Scholar
  131. Perez CA, Bedwinek JM, Breaux SR (1983) Patterns of failure after treatment of gynecologic tumors. Cancer Treat Symp 2:217Google Scholar
  132. Perez CA, Camel HM, Galakatos AE, Grigsby PW, Kuske RR, Buchsbaum G, Hederman MA (1988) Definitive irradiation in carcinoma of the vagina: long-term evaluation of results. Int J Radiat Oncol Biol Phys 15:1283–1290PubMedGoogle Scholar
  133. Perez CA, Slessinger E, Grigsby PW (1990) Design of an afterloading vaginal applicator (MIRALVA). Int J Radiat Oncol Biol Phys 18:1503PubMedGoogle Scholar
  134. Perez CA, Gersell DJ, Hoskins WJ, McGuire WP (1992) Vagina. In: Hoskins WJ, Perez CA, Young RC (eds) Principles and practice of gynecologic oncology. Lippincott, Philadephia, pp 567–590Google Scholar
  135. Perren T, Farrant M, McCarthy K, Harper P, Wiltshaw E (1992) Lymphomas of the cervix and upper vagina: a report of five cases and a review of the literature. Gynecol Oncol 44:87–95PubMedGoogle Scholar
  136. Peters WA III, Juman NB, Morley GW (1985a) Carcinoma of the vagina: factors influencing outcome. Cancer 55:892–897PubMedGoogle Scholar
  137. Peters WA III, Kumar NB, Andersen WA, Morley GW (1985b) Primary sarcoma of the adult vagina: a clinicopathologic study. Obstet Gynecol 65:699–704Google Scholar
  138. Piver MS, Rose PG (1988) Long-term follow-up and complications of infants with vulvovaginal embryonal rhabdomyosarcoma treated with surgery, radiation therapy, and chemotherapy Obstet Gynecol 71:435–437PubMedGoogle Scholar
  139. Piver MS, Barlow JJ, Wang JJ, Shah NK (1973) Combined radical surgery, radiation therapy and chemotherapy in infants with vulvo-vaginal embryonal rhabdomyosarcoma. Obstet Gynecol 42:522–526PubMedGoogle Scholar
  140. Piver MS, Barlow JJ, Xynos FP (1978) Adriamycin alone or in combination in 100 patients with carcinoma of the cervix or vagina. Am J Obstet Gynecol 131:311–313PubMedGoogle Scholar
  141. Pienti AA, Friedman EA (1971) Lymphatic system of the female genitalia: the morphologic basis of oncologic diagnosis and therapy. Saunders, Philadelphia, pp 51–74Google Scholar
  142. Powell JL, Franklin EW III, Nickerson JF, Burrell MO (1978) Verrucous carcinoma of the female genital tract. Gynecol Oncol 6:565–573PubMedGoogle Scholar
  143. Pratt CB, Husto HO, Fleming ID, Pinkel D (1972) Combination treatment of childhood rhabdomyosarcoma with surgery, radiotherapy, and combination chemotherapy. Cancer Res 32:606–610PubMedGoogle Scholar
  144. Prempree T, Amornmarn R (1985) Radiation treatment of primary carcinoma of the vagina: patterns of failure after definitive therapy. Acta Radiol Oncol 24:51–56PubMedGoogle Scholar
  145. Prempree T, Tang C-K, Hatef A, Forster S (1983) Angiosarcoma of the vagina: a clinicopathologic report. A reappraisal of radiation treatment of angiosarcomas of the female genital tract. Cancer 51:618–622PubMedGoogle Scholar
  146. Prévot S, Hugol D, Audouin J, Diebold J, Truc JB, Decroix Y, Poitout P (1992) Primary non-Hodgkin’s malignant lymphoma of the vagina: report on three cases and review of the literature. Pathol Res Pract 188:78–85PubMedGoogle Scholar
  147. Pride GL, Schultz AE, Chuprevich TW, Buchler D (1979) Primary invasive squamous carcinoma of the vagina. Obstet Gynecol 53:218–225PubMedGoogle Scholar
  148. Puthawala A, Syed AMN, Nalick R, McNamara C, DiSaia PJ (1983) Integrated external and interstitial radiation therapy for primary carcinoma of the vagina. Obstet Gynecol 62:367–372PubMedGoogle Scholar
  149. Ragni MV, Tobon H (1974) Primary malignant melanoma of the vagina and vulva. Obstet Gynecol 43:658–664PubMedGoogle Scholar
  150. Ramzy I, Smont MS, Collins JA (1976) Verrucous carcinoma of the vagina. Am J Clin Pathol 65:644PubMedGoogle Scholar
  151. Raney RB Jr, Gehan EA, Hays DM, Tefft M, Newton WA Jr, Haeberlen V, Maurer HM (1990) Primary chemotherapy with or without radiation therapy and/or surgery for children with localized sarcoma of the bladder, prostate, vagina, uterus, and cervix: a comparison of the results in Intergroup Rhabdomyosarcoma Studies I and II. Cancer 66:2072–2081PubMedGoogle Scholar
  152. Reddy S, Lee MS, Graham JE, et al. (1987) Radiation therapy in primary carcinoma of the vagina. Gynecol Oncol 26:19–24PubMedGoogle Scholar
  153. Reddy S, Saxena VS, Reddy S, et al. (1991) Results of radiotherapeutic management of primary carcinoma of the vagina. Int J Radiat Oncol Biol Phys 21:1041PubMedGoogle Scholar
  154. Reid GC, Schmidt RW, Roberts JA, Hopkins MP, Barrett RJ, Morley GW (1989) Primary melanoma of the vagina: a clinicopathologic analysis. Obstet Gynecol 74:190–199PubMedGoogle Scholar
  155. Robboy SJ, Welch WR (1977) Microglandular hyperplasia in vaginal adenosis associated with oral contraceptives and prenatal diethylstilbestrol exposure. Obstet Gynecol 49:430PubMedGoogle Scholar
  156. Robboy SJ, Herbst AL, Scully RE (1974) Clear cell adenocarcinoma of the vagina and cervix in young females: analysis of 37 tumors that persisted or recurred after primary therapy. Cancer 34:606–614PubMedGoogle Scholar
  157. Robboy SJ, Scully RE, Herbst AL (1975) Pathology of vaginal and cervical abnormalities associated with prenatal exposure to diethylstilbesterol. J Reprod Med 15:13PubMedGoogle Scholar
  158. Robboy SJ, Prat J, Welch WR (1977a) Squamous cell neoplasia controversy in the female exposed to diethylstilbestrol. Hum Pathol 8:483PubMedGoogle Scholar
  159. Robboy SJ, Scully RE, Welch WR, Herbst AL (1977b) Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions. Arch Pathol Lab Med 101:1PubMedGoogle Scholar
  160. Robboy SJ, Keh PC, Nickerson RJ, et al. (1978) Squamous cell dysplasia and carcinoma in situ of the cervix and vagina after prenatal exposure to diethylstilbestrol. Obstet Gynecol 51:528–535PubMedGoogle Scholar
  161. Robboy SJ, Kaufman RH, Prat J, et al. (1979) Pathologic findings in young women enrolled in the national cooperative diethylstilbestrol adenosis (DESAD) project. Obstet Gynecol 53:309–317PubMedGoogle Scholar
  162. Robboy SJ, Szyfelbein WM, Goellner JR, et al. (1981) Dysplasia and cytologic findings in 4589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project. Am J Obstet Gynecol 140:579–586PubMedGoogle Scholar
  163. Robboy SJ, Welch WR, Young RH, Truslow GY, Herbst AL, Scully RE (1982) Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinoma. Obstet Gynecol 60:546PubMedGoogle Scholar
  164. Robboy SJ, Hill EC, Sandberg EC, Czernobilsky B (1986) Vaginal adenosis in women born prior to the diethylstilbestrol era. Hum Pathol 17:488–492PubMedGoogle Scholar
  165. Robboy SJ, Noller KL, O’Brien P, et al. (1984) Increased incidence of cervical and vaginal dysplasia in 3980 diethylstilbestrol-exposed young women: experience of the National Collaborative Diethylstilbestrol Adenosis Project. JAMA 252:2959Google Scholar
  166. Rogo KO, Andersson R, Edbom G, Stendahl U (1991) Conservative surgery for vulvovaginal melanoma. Eur J Gynaecol Oncol 12:113–119PubMedGoogle Scholar
  167. Rubin P (1983) Clinical oncology: a multidisciplinary approach, 6th edn. American Cancer Society, AtlantaGoogle Scholar
  168. Rubin SC, Young J, Mikuta JJ (1985) Squamous carcinoma of the vagina: treatment, complications, and long-term follow-up. Gynecol Oncol 20:346–353PubMedGoogle Scholar
  169. Rutledge F (1967) Cancer of the vagina. Am J Obstet Gynecol 97:635–655PubMedGoogle Scholar
  170. Ryan TP, Taylor JH, Coughlin CT (1992) Interstitial microwave hyperthermia and brachytherapy for malignancies of the vulva and vagina. I. Design and testing of a modified intracavitary obturator. Int J Radiat Oncol Biol Phys 23:189–199PubMedGoogle Scholar
  171. Sandberg EC (1968) The incidence and distribution of occult vaginal adenosis. Am J Obstet Gynecol 101:322PubMedGoogle Scholar
  172. Sandberg EC, Danielson RW, Cauwet RW, et al. (1965) Adenosis vaginae. Am J Obstet Gynecol 93:209PubMedGoogle Scholar
  173. Sedlis A, Robboy SJ (1987) Disease of the vagina. In: Kurman RJ (ed) Blaustein’s pathology of the female genital tract. Springer, Berlin Heidelberg New York, p 113Google Scholar
  174. Senekjian EK, Frey KW, Anderson D, Herbst AL (1987) Local therapy in stage I clear cell adenocarcinoma of the vagina. Cancer 60:1319–1324PubMedGoogle Scholar
  175. Senekjian EK, Frey KW, Stone C, Herbst AL (1988) An evaluation of stage II vaginal clear cell adenocarcinoma according to substages. Gynecol Oncol 31:56–64PubMedGoogle Scholar
  176. Senekjian EK, Frey K, Herbst AL (1989) Pelvic exenteration in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol 34:413–416PubMedGoogle Scholar
  177. Sharma SC, Bhandare N (1991) A new design of Delclos dome cylinders using standard Cs-137 sources. Int J Radiat Oncol Biol Phys 21:511–514PubMedGoogle Scholar
  178. Sharma SC, Gerbi B, Madoc-Jones H (1979) Dose rates for brachytherapy applicators using137Cs sources. Int J Radiat Oncol Biol Phys 5:1893PubMedGoogle Scholar
  179. Shevchuk M, Fenoglio CM, Lattes R, et al. (1978) Malignant mixed tumor of the vagina probably arising in meso-nephric rests. Cancer 42:214PubMedGoogle Scholar
  180. Shimm DS, Ropar M (1986) Radiation therapy of carcinoma of the vagina. Acta Obstet Gynecol Scand 65:449–452PubMedGoogle Scholar
  181. Shpikalov VL, Atkochyus VB (1989) Interstitial radiotherapy of malignant tumors of the vagina. Neoplasma 36:729–737PubMedGoogle Scholar
  182. Slayton RE, Blessing JA, Beecham J, et al. (1987) Phase II trial of etoposide in the management of advanced or recurrent squamous carcinoma of the vulva and carcinoma of the vagina: a Gynecologic Oncology Group Study. Cancer Treat Rep 71:869–870PubMedGoogle Scholar
  183. Son YH (1980) Primary mucosal malignant melanoma: appraisal of role of radiation therapy. Acta Radiol Oncol 19:177PubMedGoogle Scholar
  184. Spirtos NM, Doshi BP, Kapp DS, Teng N (1989) Radiation therapy for primary squamous cell carcinoma of the vagina: Stanford University experience. Gynecol Oncol 35:20–26PubMedGoogle Scholar
  185. Stafl A, Mattingly RF (1974) Vaginal adenosis: a precancerous lesion? Am J Obstet Gynecol 120:666PubMedGoogle Scholar
  186. Steeper TA, Piscioli F, Rosai J (1983) Squamous cell carcinoma with sarcoma-like stroma of the female genital tract. Cancer 52:890PubMedGoogle Scholar
  187. Stock RG, Mychalczak B, Armstrong JG, Curtin JP, Harrison LB (1992) The importance of brachytherapy technique in the management of primary carcinoma of the vagina. Int J Radiat Oncol Biol Phys 24:747–753PubMedGoogle Scholar
  188. Stuart GC, Allen HH, Anderson RJ (1981) Squamous cell carcinoma of the vagina following hysterectomy. Am J Obstet Gynecol 139:311–315PubMedGoogle Scholar
  189. Sutton GP, Blessing JA, Rosenshein N, Photopulos G, DiSaia PJ (1989) Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study). Am J Obstet Gynecol 161:309–312PubMedGoogle Scholar
  190. Tarraza MH Jr, Muntz H, Decain M, Granai OC, Fuller A Jr (1991) Patterns of recurrence of primary carcinoma of the vagina. Eur J Gynaecol Oncol 12:89–92PubMedGoogle Scholar
  191. Tavassoli FA, Norris HJ (1979) Smooth muscle tumors of the vagina. Obstet Gynecol 53:689–693PubMedGoogle Scholar
  192. Thigpen JT, Blessing JA, Homesley HD, Berek JS, Creasman WT (1986a) Phase II trial of cisplatin in advanced or recurrent cancer of the vagina: a Gynecologic Oncology Group Study. Gynecol Oncol 23:101–104PubMedGoogle Scholar
  193. Thigpen JT, Blessing JA, Orr JW, DiSaia PJ (1986b) Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesoderma sarcomas of the uterus: a Gynecologic Oncology Group Study. Cancer Treat Rep 70:271–274PubMedGoogle Scholar
  194. Tobon H, Murphy AI, Salazar H (1973) Primary leiomyosarcoma of the vagina: light and electron microscopic observation. Cancer 32:450PubMedGoogle Scholar
  195. Togashi K, Nishimura K, Itoh K, et al. (1986) Uterine cervical cancer: assessment with high-field MR imaging. Radiology 160:431–435PubMedGoogle Scholar
  196. Townsend DE (1981) Intraepithelial neoplasia of the vagina. In: Coppleson M (ed) Gynecologic oncology: fundamental principles and clinical practice. Churchill Livingstone, New York, pp 339–344Google Scholar
  197. Ulbright TM, Kraus FT (1981) Endometrial stromal tumors of extra-uterine tissue. Am J Clin Pathol 76:371PubMedGoogle Scholar
  198. Ulich TR, Liao S-Y, Layfield L, Romansky S, Cheng L, Lwein KT (1986) Endocrine and tumor differentiation markers in poorly differentiated small-cell carcinoids of the cervix and vagina. Arch Pathol Lab Med 110:1054–1057PubMedGoogle Scholar
  199. Underwood RB, Smith RT (1971) Carcinoma of the vagina. JAMA 217:46–52PubMedGoogle Scholar
  200. Vayrynen M, Romppanen T, Koskela E, Castren O, Syrjanen K (1981) Verrucous squamous cell carcinoma of the female genital tract: report of three cases and survey of the literature. Int J Gynaecol Obstet 19:351–356PubMedGoogle Scholar
  201. Wasserman TH, Stetz J, Phillips TL (1980) Clinical trials of misonidazole in the United States. In: Brady LW (ed) Radiation sensitizers: their use in the clinical management of cancer. Masson, New York, pp 387–396Google Scholar
  202. Way S (1948) Primary carcinoma of the vagina. J Obstet Gynaecol Br Emp 55:739Google Scholar
  203. Webb MJ, Symmonds RE, Weiland LH (1974) Malignant fibrous histiocytoma of vagina. Am J Obstet Gynecol 119:190PubMedGoogle Scholar
  204. Wharton JT, Rutledge FN, Gallagher HS, Fletcher G (1975) Treatment of clear cell adenocarcinoma in young females. Obstet Gynecol 43:365–368Google Scholar
  205. Whelton J, Kottmeier HL (1962) Primary carcinoma of the vagina. Acta Obstet Gynecol Scand 41:22–40PubMedGoogle Scholar
  206. Woodman CB, Mould JJ, Jordan JA (1988) Radiotherapy in the management of vaginal intraepithelial neoplasia after hysterectomy. Br J Obstet Gynaecol 95:976–979PubMedGoogle Scholar
  207. Woodruff JD, Parmley TH, Julian CG (1975) Topical 5-fluorouracil in the treatment of vaginal carcinoma in situ. Gynecol Oncol 3:124PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • C. A. Perez
    • 1
  1. 1.Radiation Oncology Center, Mallinckrodt Institute of RadiologyWashington University Medical CenterUSA

Personalised recommendations